软骨标志物CTX-Ⅱ在骨关节炎中的应用
摘要点击次数: 2781   全文下载次数: 1749   投稿时间:2012-04-08    
作者Author单位AddressE-Mail
王学宗 WANG Xue-zong 上海中医药大学附属曙光医院, 上海 201203 Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
高宁阳 GAO Ning-yang 上海中医药大学附属曙光医院, 上海 201203 Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
刘婷 LIU Ting 上海中医药大学附属曙光医院, 上海 201203 Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
沈军 SHEN Jun 上海中医药大学附属曙光医院, 上海 201203 Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
韦宋谱 WEI Song-pu 上海中医药大学附属曙光医院, 上海 201203 Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
郑昱新 ZHENG Yu-xin 上海中医药大学附属曙光医院, 上海 201203 Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
曹月龙 CAO Yue-long* 上海中医药大学附属曙光医院, 上海 201203
上海市中医药研究院骨伤科研究所, 上海 201203
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China ningtcm@126.com 
詹红生 ZHAN Hong-sheng 上海中医药大学附属曙光医院, 上海 201203
上海市中医药研究院骨伤科研究所, 上海 201203
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China  
期刊信息:《中国骨伤》2013年,第26卷,第3期,第260-263页
DOI:10.3969/j.issn.1003-0034.2013.03.023
基金项目:“中医骨伤科学”国家重点学科(编号:100508);国家自然科学基金(编号:81072830,81173277);上海市教委创新项目(编号:11YZ64)
中文摘要:骨关节炎(OA)的临床诊断尚缺乏有效的生物学标志物。研究证实标志物Ⅱ型胶原羧基端交联肽(CTX-Ⅱ)是关节软骨降解的特异性指标。CTX-Ⅱ检测可及时反映软骨损伤和退变程度、诊断OA发生、预测OA进展和监测药物治疗效果,从而间接反映OA患者的病情。CTX-Ⅱ的应用主要集中于OA早期,并需联合其他生物学标志物一起检测,以便更准确的反映OA病变,但其检测结果具体临床指导意义还需进一步完善。
【关键词】骨关节炎  软骨  综述文献
 
Application of biomarker CTX-Ⅱ in osteoarthritis
ABSTRACT  Effective biomarkers for clinical usage of osteoarthritis are still limited. It was confirmed that C-terminal crosslinking telopeptide of typeⅡcollagen (CTX-Ⅱ) was a specific marker reflecting degradation of articular cartilage. Detection of CTX-Ⅱ could promptly reflect level of cartilage injury and degradation,diagnose OA,predict its progress,monitor effects of drug treatment,thus,reflect the condition of osteoarthritis patient indirectly. Application of CTX-Ⅱ focused mainly on in the early stage of OA and need together to detect with other biomarkers,in order to more accurately reflection of the pathological changes of OA,but the specific clinical significance of CTX-Ⅱ results still need to improve further.
KEY WORDS  Osteoarthritis  Cartilage  Review literature
 
引用本文,请按以下格式著录参考文献:
中文格式:王学宗,高宁阳,刘婷,沈军,韦宋谱,郑昱新,曹月龙,詹红生.软骨标志物CTX-Ⅱ在骨关节炎中的应用[J].中国骨伤,2013,26(3):260~263
英文格式:WANG Xue-zong,GAO Ning-yang,LIU Ting,SHEN Jun,WEI Song-pu,ZHENG Yu-xin,CAO Yue-long*,ZHAN Hong-sheng.Application of biomarker CTX-Ⅱ in osteoarthritis[J].zhongguo gu shang / China J Orthop Trauma ,2013,26(3):260~263
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号